Gastrointestinal Stent Market worth $0.82 billion by 2031
Author : Pratik Chavare | Published On : 25 May 2026
The report "Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031" The global gastrointestinal stent market is projected to reach USD 0.82 billion by 2031 from USD 0.62 billion in 2026, at a CAGR of 5.7% during the forecast period.
Browse 480 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on "Gastrointestinal Stent Market By Product (Duodenal, Pancreatic, Colonic, Biliary), Type [Metal (SEMS, Balloon-expandable, Nitinol, Stainless Steel), Plastic, Biodegradable], Application (Colorectal & Stomach Cancer), End User - Global Forecast to 2031"
Download PDF- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167758126
The gastrointestinal stent market is poised for a robust expansion as prevalent cases of gastrointestinal cancers, benign disorders' incidences, and the upsurge in the adoption of minimally invasive endoscopic surgeries are some of the reasons behind it. Besides, continuous improvements in stent and biomaterial design contribute to the growth potential of the gastrointestinal stent market. The rising need for the management of strictures, obstructions, leaks, and fistula through effective, safe, and cost-effective methods is pushing the presence of self-expanding metal stents (SEMS), biodegradable stents, and drug-eluting stents in the hospital and specialty endoscopy center market.
The latest advancements, such as anti-migration mechanisms, better radial forces, and flexible low-profile delivery systems, along with bio-compatible coatings, help not only increase procedure technical success but also patient outcomes. Besides these, a stronger focus on early treatment, less hospital stay, increasing healthcare spending, and opening up to advanced endoscopic treatment are some of the important factors that are leading to the growing demand for gastrointestinal stents in the market.
By type, the metal stents segment accounted for the largest market share in 2025.
In the gastrointestinal stent market, the metal stents segment accounted for the largest market share in 2025. This dominance is primarily because of their better mechanical strength, greater radial force, and longer patency than other materials, which renders them very effective in handling malignant stenoses and obstructions. Self-expanding metal stents (SEMS) are favored among physicians since they can better fit even very complicated GI anatomies, are less likely to be crushed, and give better clinical results, especially in cancer treatments. Besides that, innovations such as covered and partially covered designs have not only minimized problems like tumor ingrowth and migration but have also played a significant role in their widespread usage in esophageal, biliary, and colonic cases.
By application, the gastrointestinal cancers segment is expected to grow at the highest CAGR during the forecast period.
The gastrointestinal stent segment is expected to grow at the highest CAGR during the forecast period because the rise in incidence rates of various types of cancers all over the world has led to the increased demand for esophageal, colorectal, and gastric cancer treatments. These cancers that lead to luminal obstructions require immediate palliative intervention. In such cases, GI stents are most commonly used as they are capable to bridge the period from presentation to definitive treatment. They are procured for both malignant and benign obstructions to provide patients with symptom relief and eliminate the need for surgical interventions. Besides this, increasing palliative care and cancer diagnosis rates, along with technological developments such as covered and drug-eluting stents, are some of the contributing factors to the faster growth of their usage in oncology settings as opposed to benign indications.
By region, North America accounted for the largest share of the market in 2025.
In 2025, North America accounted for the largest share of the gastrointestinal stent market. This is mainly because it has a developed healthcare system, a high percentage of minimally invasive endoscopic procedures being performed, and many leading medical device manufacturers are located there. The area also experiences a high number of gastrointestinal cancer cases and other related disorders, which maintains the demand for stent-based operations. Besides, positive reimbursement rules, early introduction of new types of stents such as drug-eluting and biodegradable ones, and a good endoscopist network contribute to the high usage of these devices and help the region keep its leading position in the market.
Key Market Players
The prominent players in the gastrointestinal stent market are Boston Scientific Corporation (US), Cook Medical (US), Medtronic plc (Ireland), Olympus Corporation (Japan), BD (US), M.I.Tech Co., Ltd. (South Korea), W. L. Gore & Associates, Inc. (US), Endo-Flex GmbH (Germany), Micro-Tech (Nanjing) Co., Ltd. (China), Hobbs Medical Inc. (US), Merit Medical Systems, Inc. (US), BVM Medical Limited (UK), STERIS plc (Ireland), ELLA-CS, s.r.o. (Czech Republic), Q3 Medical Group (Netherlands), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
o several key factors. Increased awareness of sleep apps and their benefits has led more people to take up these solutions. Changes in lifestyle, including the widespread adoption of work-from-home models, have significantly increased screen time, which is one of the main reasons for disrupted sleep patterns. Furthermore, increased focus on mental and physical wellness has emphasized the importance of quality sleep for overall health. These combined drivers make general sleep improvement apps a popular choice for addressing diverse sleep challenges.
Asia Pacific to witness a considerable growth rate during the forecast period.
The sleep software market is segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to demonstrate significant growth with a noticeable annual growth rate during the forecast period. The growing recognition of sleep disorders and the need for improved sleep medicine education in Asia significantly drive the market for sleep software in the region. As the prevalence of conditions like obstructive sleep apnea, insomnia, and circadian rhythm disorders rises, there is a critical need for better training, education, and regulation of sleep medicine practices. The push for improved sleep health services, coupled with the integration of digital tools for real-time monitoring and management, will further accelerate the adoption of sleep software. As momentum builds in the effort to close educational and resource disparities, demand for advanced sleep software solutions will grow, fueling growth in the region.
Key Players
Koninklijke Philips N.V. (Netherlands), Cadwell Industries Inc. (US), COMPUMEDICS LIMITED (Australia), NIHON KOHDEN CORPORATION (Japan), Natus Medical Incorporated (ARCHIMED) (US), Resmed (US), Calm (US), Sleep Cycle (Sweden), Headspace Inc. (US), Löwenstein Medical SE & Co. KG (Germany), CamNtech Ltd (United Kingdom), Fisher & Paykel Healthcare Limited. (New Zealand), and Inspire Medical Systems, Inc. (US) are the major players in this market. These companies are majorly focusing on strategies such as acquisitions, collaborations, partnerships, expansion, and product launches and updates to remain competitive and further increase their share in the market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
